Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07359820
Recruiting
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
Phase 2 · Spain, France, United Kingdom, South Korea, United States · 19 sites
Registry update: 3 Sept 2026
NCT07732907
Recruiting
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
Not applicable · United States · 1 site
Registry update: 29 Jul 2026
NCT07286331
Recruiting
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Phase 3 · Argentina, Australia, Brazil, Canada, United Kingdom, Israel, Japan, South Korea, Panama, United States · 44 sites
Registry update: 3 Nov 2026
NCT07682311
Recruiting
Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator
Not applicable · United States · 1 site
Registry update: 14 Sept 2026
NCT07049653
Recruiting
Anifrolumab Pregnancy Study
Not applicable · United States · 1 site
Registry update: 18 Sept 2026
2025-523704-77-00
Recruiting
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneration.
Phase 2 · Bulgaria, Czechia, Germany, Spain, France, Hungary, Italy, Poland, Romania · 30 sites
Registry update: 23 Jun 2026
NCT07572526
Recruiting
tDCS: Sleep to Mood in Depression (S2M-D)
Not applicable · United States · 1 site
Registry update: 8 Jun 2026
NCT07684911
Recruiting
Longitudinal Study on the Sustainability of Transcranial Magnetic Stimulation Protocols - Biomarkers
Not applicable · France · 1 site
Registry update: 6 Jul 2026
NCT07884994
Recruiting
HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New Platform
Not applicable · Germany · 1 site
Registry update: 21 Oct 2026
NCT07359482
Recruiting
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Phase 3 · Netherlands · 1 site
Registry update: 9 Jun 2026
NCT07702149
Recruiting
Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus
Not applicable · Egypt · 2 sites
Registry update: 14 Jul 2026
NCT07672119
Recruiting
A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide
Not applicable · United States · 1 site
Registry update: 26 Jun 2026
NCT07486817
Recruiting
Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
Phase 2 · Australia, China, Germany, Spain, France, Japan, South Korea · 17 sites
Registry update: 1 Sept 2026
NCT07570823
Recruiting
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 3 · China · 1 site
Registry update: 13 Aug 2026
NCT07645820
Recruiting
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Not applicable · United States · 13 sites
Registry update: 20 Oct 2026
NCT07636382
Recruiting
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain
Not applicable · Canada · 1 site
Registry update: 30 Jul 2026
2025-521587-35-00
Recruiting
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)
Phase 3 · Belgium, Czechia, Germany, Spain, France, Hungary, Ireland, Italy, Poland · 108 sites
Registry update: 16 Oct 2026
NCT07656805
Recruiting
Anti-inflammatory Dietary Intervention in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Not applicable · China · 1 site
Registry update: 18 Jun 2026
NCT07620392
Recruiting
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Phase 2 · Belgium, Brazil, Germany, Denmark, Spain, France, Italy, Poland, United States · 35 sites
Registry update: 16 Oct 2026
NCT07195708
Recruiting
Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')
Not applicable · China · 1 site
Registry update: 27 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.